Lessons for the nascent regenerative medicine industry from the biotech sector.
Mason
Chris
C
Dunnill
Peter
P
D001709:Biotechnology / Q000191:economics / Q000379:methods* / Q000639:trends*; D006801:Humans; D007221:Industry / Q000191:economics / Q000639:trends*; D044968:Regenerative Medicine / Q000379:methods*